The monoclonal antibodies in veterinary health market face growth opportunities due to rising animal chronic diseases and pet ...

In the treatment of inflammatory bowel disease, synthetic mucus gels can be used to deliver monoclonal antibodies without inducing broad immunosuppression.

Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...

NMPA accepts Akeso’s supplemental New Drug Application for gumokimab to treat active ankylosing spondylitis: Hong Kong Wednesday, January 21, 2026, 12:00 Hrs [IST] Akeso Inc, a ...

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...

OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) Nantes, France, January 21, ...

A new computer model could help predict and improve antibody drug formulations. The goal is for patients to be able to ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

As cancer cases climb steadily across India, lower-cost biosimilars like Tishtha could reshape access to life-saving immunotherapy.

Amid a surprisingly severe flu season and a Covid-19 resurgence, those highly contagious respiratory illnesses are drawing ...

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced it has entered into a clinical trial collaboration with GSK plc ("GSK ...

Bio-Sourcing and Zerion Pharma have obtained a €1.3 million EU grant reward under the Eurostars program to advance an orally administered anti-HER2, antibody Trastuzimab, for treatment of breast cance ...